From the Journals

COVID-19 antibody response not reduced with diabetes

Publish date: October 20, 2020

 

A version of this article originally appeared on Medscape.com.

Pages

Recommended Reading

Evaluation of Glycemic Control and Cost Savings Associated With Liraglutide Dose Reduction at a Veterans Affairs Hospital
Type 2 Diabetes ICYMI
Choosing Wisely: 10 practices to stop—or adopt—to reduce overuse in health care
Type 2 Diabetes ICYMI
Chronic, nonhealing leg ulcer
Type 2 Diabetes ICYMI
Empagliflozin cut PA pressures in heart failure patients
Type 2 Diabetes ICYMI
T2D treatments create tension between glycemic and cardiovascular goals
Type 2 Diabetes ICYMI
These images of diabetic retinopathy tell the story better
Type 2 Diabetes ICYMI
Entresto halves renal events in preserved EF heart failure patients
Type 2 Diabetes ICYMI
Substance in tears could be used for diabetes monitoring
Type 2 Diabetes ICYMI
Recall widens for diabetes drug metformin
Type 2 Diabetes ICYMI
Diabetic neuropathic pain linked to brain bioenergic anomalies
Type 2 Diabetes ICYMI